![Kathleen Tregoning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Tregoning
Directeur/Bestuurslid bij
SPERO THERAPEUTICS, INC.
Vermogen: 87 750 $ op 31-07-2026
Profiel
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021, an Independent Director at Compass Pathways Plc starting in 2026, and Chief Corporate Affairs Officer at Kailera Therapeutics, Inc. starting in 2026.
Former positions include Member of the United States Congress, Executive Vice President-External Affairs at Sanofi from 2017 to 2020, Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. from 2020 to 2024, and Senior Vice President-Corporate Affairs at Biogen, Inc. from 2015 to 2017.
Education includes undergraduate studies at Stanford University and graduate studies at Harvard Kennedy School of Government.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-06-2026 | 75.000 ( 0,13% ) | 87 750 $ | 31-07-2026 | |
COMPASS PATHWAYS PLC -.--% | 27-05-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Kathleen Tregoning
| Bedrijven | Functie | Begin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-10-2021 |
| COMPASS PATHWAYS PLC | Directeur/Bestuurslid | 06-04-2026 |
Eerdere bekende functies van Kathleen Tregoning
| Bedrijven | Functie | Einde |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 01-08-2024 |
| SANOFI | Public Communications Contact | 01-03-2020 |
| BIOGEN INC. | Algemeen Adviseur | 01-12-2015 |
United States Congress | Corporate Officer/Principal | - |
Opleiding van Kathleen Tregoning
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
89
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Harvard Kennedy School of Government
 Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
United States Congress |
